Evoq Remedies IPO
subscription status is to start from March 17, 2022, Thursday. The IPO is been subscribed by NII and Retail investors. Evoq Remedies is a BSE SME IPO
and they are going to raise ₹9.72 crores
via SME IPO. The company was incorporated in 2010 based in Ahmedabad. The company is doing marketing, trading and distribution of pharmaceutical formulation products. The product range includes anti-biotic drugs, anti-malarial drugs, anti-allergic & anti cold drugs, analgesic/ anti-pyretic & anti inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastro intestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants, and injections. The company reported ₹10.02 crores of revenues
in 2021 against ₹9.07 crores in 2020. The company’s financial report looks fine
while profit is growing year on year but still on a lower side. Please check the Evoq Remedies IPO subscription status details over here.
How to apply the Evoq Remedies IPO? You can apply Evoq Remedies IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the Evoq Remedies IPO in the Invest section. The other option you can apply Evoq Remedies IPO via IPO forms download via BSE website. Check out the Evoq Remedies forms – click BSE IPO Forms download, fill and submit in your bank or with your broker.